Diligence memo · auto-generated · as of July 2, 2026

Unilife Corp

Unilife Corp looks under-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Unilife Corp operates in Other Health Care, based in York.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Unilife Corp has raised $46M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).

Largest single filing: $30M on 2016-02-22.

Most recent recorded round closed around 2016-12-20.

Valuation (modeled)modeled

Provath models Unilife Corp at approximately $111M (range $12M–$426M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.25× the median modeled value of Series B Other Health Care companies in 2016–2018 (74 peers) — value vs value, same stage and era. Issuer reports $5M–$25M revenue while modeled below niche peers.

Financing rhythm & timingmixed

Historic cadence: a new round about every 5 months.

Last raise 9.5 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round was 2.1× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 91% of Other Health Care peers (5377 compared).

Modeled value ranks above 81% of those peers.

Closest niche peers: Podicare Services, Inc., COTA, Inc., Fresenius Medical Care - Meridian Health System, LLC, Headspace, Inc., Spine Holdings LLC.

Peoplefiled

23 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.